Clinical Trial Update: A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma [Phase 4]

View source ↗

Summary

This clinical trial update reports a Phase 4 study of pirtobrutinib (LY3527727) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Pirtobrutinib (pirtobrutinib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma | Phase 4 | Status: RECRUITING